v3.26.1
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT (EQUITY) (UNAUDITED) - USD ($)
Class A ordinary shares [Member]
Common Stock [Member]
Class B ordinary shares [Member]
Common Stock [Member]
Additional Paid-in Capital
Accumulated Deficit
Total
Balance (in Shares) at Nov. 30, 2025 7,666,667 [1]      
Balance at Nov. 30, 2025 $ 767 $ 24,233 $ (7,247) $ 17,753
Net income (loss) (87,593) (87,593)
Balance (in Shares) at Feb. 28, 2026 7,666,667 [1]      
Balance at Feb. 28, 2026 $ 767 24,233 (94,840) (69,840)
Balance (in Shares) at Nov. 30, 2025 7,666,667 [1]      
Balance at Nov. 30, 2025 $ 767 24,233 (7,247) 17,753
Net income (loss)         1,837,551
Balance (in Shares) at May. 31, 2026 625,000 7,666,667      
Balance at May. 31, 2026 $ 63 $ 767 (7,193,334) (7,192,504)
Balance (in Shares) at Feb. 28, 2026 7,666,667 [1]      
Balance at Feb. 28, 2026 $ 767 24,233 (94,840) (69,840)
Net income (loss) 1,925,144 1,925,144
Accretion for Class A Ordinary Shares to redemption amount (9,075,849) (9,023,638) (18,099,487)
Sale of 625,000 Private Placement Units 625,000      
Sale of 625,000 Private Placement Units $ 63 6,249,937 6,250,000
Fair value of Public Warrants at issuance 2,990,000 2,990,000
Allocated value of transaction costs to Class A Ordinary Shares (188,321) (188,321)
Balance (in Shares) at May. 31, 2026 625,000 7,666,667      
Balance at May. 31, 2026 $ 63 $ 767 $ (7,193,334) $ (7,192,504)
[1] As of November 30, 2025, includes 1,000,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On February 27, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As a result, the 1,000,000 Founder Shares are no longer subject to forfeiture (Note 7).